{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T04:12:10Z","timestamp":1787976730693,"version":"build-2784847793"},"reference-count":67,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Science Foundation of China","doi-asserted-by":"crossref","award":["81172573"],"award-info":[{"award-number":["81172573"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Science Foundation of China","doi-asserted-by":"crossref","award":["81101916"],"award-info":[{"award-number":["81101916"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["cancerletters.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.canlet.2015.02.042","type":"journal-article","created":{"date-parts":[[2015,2,26]],"date-time":"2015-02-26T14:30:25Z","timestamp":1424961025000},"page":"1-7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Role of runt-related transcription factor 2 in signal network of tumors as an inter-mediator"],"prefix":"10.1016","volume":"361","author":[{"given":"Shan-Shan","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingxuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2015.02.042_bib0010","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/jcb.20420","article-title":"Regulation of skeletal development by the Runx family of transcription factors","volume":"95","author":"Komori","year":"2005","journal-title":"J. Cell. Biochem"},{"key":"10.1016\/j.canlet.2015.02.042_bib0015","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s00441-009-0832-8","article-title":"Regulation of bone development and extracellular matrix protein genes by RUNX2","volume":"339","author":"Komori","year":"2010","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.canlet.2015.02.042_bib0020","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0092-8674(00)80259-7","article-title":"Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development","volume":"89","author":"Otto","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2015.02.042_bib0025","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0092-8674(02)00690-6","article-title":"Causal relationship between the loss of RUNX3 expression and gastric cancer","volume":"109","author":"Li","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2015.02.042_bib0030","doi-asserted-by":"crossref","first-page":"3454","DOI":"10.1093\/emboj\/cdf370","article-title":"The Runx3 transcription factor regulates development and survival of TrkC dorsal root ganglia neurons","volume":"21","author":"Levanon","year":"2002","journal-title":"EMBO J."},{"key":"10.1016\/j.canlet.2015.02.042_bib0035","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/nn925","article-title":"Runx3 controls the axonal projection of proprioceptive dorsal root ganglion neurons","volume":"5","author":"Inoue","year":"2002","journal-title":"Nat. Neurosci"},{"key":"10.1016\/j.canlet.2015.02.042_bib0040","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/jcb.20420","article-title":"Runx2, a multifunctional transcription factor in skeletal development","volume":"95","author":"Komori","year":"2005","journal-title":"J. Cell. Biochem"},{"key":"10.1016\/j.canlet.2015.02.042_bib0045","doi-asserted-by":"crossref","first-page":"5984","DOI":"10.1210\/en.2008-0680","article-title":"Modulation of Runx2 activity by estrogen receptor-\u03b1: implications for osteoporosis and breast cancer","volume":"149","author":"Khalid","year":"2008","journal-title":"J. Endocrinol"},{"key":"10.1016\/j.canlet.2015.02.042_bib0050","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1210\/me.2008-0470","article-title":"Repression of Runx2 by androgen receptor (AR) in osteoblasts and prostate cancer cells: AR binds Runx2 and abrogates its recruitment to DNA","volume":"23","author":"Baniwal","year":"2009","journal-title":"Mol. Endocrinol"},{"key":"10.1016\/j.canlet.2015.02.042_bib0055","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1182\/blood-2008-06-162248","article-title":"Runx2 induces acute myeloid leukemia in cooperation with Cbf\u03b2-SMMHC in mice","volume":"113","author":"Kuo","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2015.02.042_bib0060","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1089\/ten.teb.2012.0527","article-title":"Transcriptional regulatory cascades in Runx2-dependent bone development","volume":"19","author":"Liu","year":"2013","journal-title":"Tissue Eng. Part B Rev"},{"key":"10.1016\/j.canlet.2015.02.042_bib0065","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1038\/sj.bjc.6603984","article-title":"Regulation and functional role of the Runt-related transcription factor-2 in pancreatic cancer","volume":"97","author":"Kayed","year":"2007","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2015.02.042_bib0070","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1186\/s12967-014-0257-3","article-title":"The prognostic significance of RUNX2 and miR-10a\/10b and their inter-relationship in breast cancer","volume":"12","author":"Chang","year":"2014","journal-title":"J. Transl. Med"},{"key":"10.1016\/j.canlet.2015.02.042_bib0075","doi-asserted-by":"crossref","first-page":"74384","DOI":"10.1371\/journal.pone.0074384","article-title":"Inhibition of RUNX2 transcriptional activity blocks the proliferation, migration and invasion of epithelial ovarian carcinoma cells","volume":"8","author":"Wang","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.canlet.2015.02.042_bib0080","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/labinvest.2009.128","article-title":"Runx2 regulates survivin expression in prostate cancer cells","volume":"90","author":"Lim","year":"2009","journal-title":"Lab. Invest"},{"key":"10.1016\/j.canlet.2015.02.042_bib0085","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1007\/s13277-013-0720-4","article-title":"Clinical significance of RUNX2 expression in patients with nonsmall cell lung cancer: a 5-year follow-up study","volume":"34","author":"Li","year":"2013","journal-title":"Tumor Biol"},{"key":"10.1016\/j.canlet.2015.02.042_bib0090","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.canlet.2014.03.011","article-title":"RUNX2 is overexpressed in melanoma cells and mediates their migration and invasion","volume":"348","author":"Boregowda","year":"2014","journal-title":"Cancer Lett"},{"key":"10.1016\/j.canlet.2015.02.042_bib0095","doi-asserted-by":"crossref","first-page":"5577","DOI":"10.1158\/0008-5472.CAN-09-4602","article-title":"Frequent attenuation of the WWOX tumor suppressor in osteosarcoma is associated with increased tumorigenicity and aberrant RUNX2 expression","volume":"70","author":"Kurek","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.canlet.2015.02.042_bib0100","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/sj.onc.1204090","article-title":"Runx2: a novel oncogenic effector revealed by in vivo complementation and retroviral tagging","volume":"20","author":"Blyth","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2015.02.042_bib0105","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1016\/j.ejca.2009.06.021","article-title":"Positive association between nuclear Runx2 and estrogen-progesterone receptor gene expression characterises a biological subtype of breast cancer","volume":"45","author":"Das","year":"2009","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.canlet.2015.02.042_bib0110","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1111\/j.1349-7006.2010.01742.x","article-title":"Runx2 in human breast carcinoma: its potential roles in cancer progression","volume":"101","author":"Onodera","year":"2010","journal-title":"Cancer Sci"},{"key":"10.1016\/j.canlet.2015.02.042_bib0115","first-page":"2631","article-title":"Osteoblast-related transcription factors Runx2 (Cbfa1\/AML3) and MSX2 mediate the expression of bone sialoprotein in human metastatic breast cancer cells","volume":"63","author":"Barnes","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.canlet.2015.02.042_bib0120","doi-asserted-by":"crossref","first-page":"6807","DOI":"10.1158\/0008-5472.CAN-09-1471","article-title":"Ectopic runx2 expression in mammary epithelial cells disrupts formation of normal acini structure: implications for breast cancer progression","volume":"69","author":"Pratap","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.canlet.2015.02.042_bib0125","doi-asserted-by":"crossref","first-page":"8581","DOI":"10.1128\/MCB.25.19.8581-8591.2005","article-title":"The Runx2 osteogenic transcription factor regulates matrix metalloproteinase 9 in bone metastatic cancer cells and controls cell invasion","volume":"25","author":"Pratap","year":"2005","journal-title":"Mol. Cell. Biol"},{"key":"10.1016\/j.canlet.2015.02.042_bib0130","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1242\/dmm.015040","article-title":"RUNX2 correlates with subtype-specific breast cancer in a human tissue microarray, and ectopic expression of Runx2 perturbs differentiation in the mouse mammary gland","volume":"7","author":"McDonald","year":"2014","journal-title":"Dis. Mod. Mech"},{"key":"10.1016\/j.canlet.2015.02.042_bib0135","doi-asserted-by":"crossref","first-page":"4322","DOI":"10.1158\/1078-0432.CCR-08-3157","article-title":"Suppression of androgen-independent prostate cancer cell aggressiveness by FTY720: validating Runx2 as a potential antimetastatic drug screening platform","volume":"15","author":"Chua","year":"2009","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.canlet.2015.02.042_bib0140","doi-asserted-by":"crossref","first-page":"E2006","DOI":"10.1210\/jc.2012-1903","article-title":"Runx2 isoform I controls a panel of proinvasive genes driving aggressiveness of papillary thyroid carcinomas","volume":"97","author":"Sancisi","year":"2012","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"10.1016\/j.canlet.2015.02.042_bib0145","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1002\/jcp.24339","article-title":"Oncogenic cooperation between PI3K\/Akt signaling and transcription factor Runx2 promotes the invasive properties of metastatic breast cancer cells","volume":"228","author":"Pande","year":"2013","journal-title":"J. Cell. Physiol"},{"key":"10.1016\/j.canlet.2015.02.042_bib0150","doi-asserted-by":"crossref","first-page":"R16","DOI":"10.1186\/bcr3611","article-title":"Runx2 activates PI3K\/Akt signaling via mTORC2 regulation in invasive breast cancer cells","volume":"16","author":"Tandon","year":"2014","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.canlet.2015.02.042_bib0155","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/1476-4598-9-171","article-title":"The Runx transcriptional co-activator, CBFbeta, is essential for invasion of breast cancer cells","volume":"9","author":"Mendoza-Villanueva","year":"2009","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2015.02.042_bib0160","doi-asserted-by":"crossref","first-page":"21307","DOI":"10.1074\/jbc.M112.445890","article-title":"MicroRNA-34c inversely couples the biological functions of the runt-related transcription factor RUNX2 and the tumor suppressor p53 in osteosarcoma","volume":"288","author":"Van der Deen","year":"2013","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.canlet.2015.02.042_bib0165","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1158\/0008-5472.CAN-10-2603","article-title":"FOXO1 inhibits Runx2 transcriptional activity and prostate cancer cell migration and invasion","volume":"71","author":"Zhang","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.canlet.2015.02.042_bib0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2014.09.076","article-title":"miR-30a inhibits osteolysis by targeting Runx2 in giant cell tumor of bone","author":"Huang","year":"2014","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"10.1016\/j.canlet.2015.02.042_bib0175","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1210\/jc.2007-2805","article-title":"Expression and function of Cbfa-1\/Runx2 in thyroid papillary carcinoma cells","volume":"93","author":"Endo","year":"2008","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"10.1016\/j.canlet.2015.02.042_bib0180","doi-asserted-by":"crossref","first-page":"e610","DOI":"10.1038\/cddis.2013.127","article-title":"Runt-related transcription factor 2 (RUNX2) inhibits p53-dependent apoptosis through the collaboration with HDAC6 in response to DNA damage","volume":"4","author":"Ozaki","year":"2013","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.canlet.2015.02.042_bib0185","doi-asserted-by":"crossref","first-page":"7795","DOI":"10.1158\/0008-5472.CAN-08-1078","article-title":"Runx2 transcriptional activation of Indian Hedgehog and a downstream bone metastatic pathway in breast cancer cells","volume":"68","author":"Pratap","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.canlet.2015.02.042_bib0190","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1158\/0008-5472.CAN-05-3558","article-title":"Runx2 and MYC collaborate in lymphoma development by suppressing apoptotic and growth arrest pathways in vivo","volume":"66","author":"Blyth","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.canlet.2015.02.042_bib0195","doi-asserted-by":"crossref","first-page":"e349","DOI":"10.1038\/cddis.2012.89","article-title":"Glucocorticoid-mediated BIM induction and apoptosis are regulated by Runx2 and c-Jun in leukemia cells","volume":"3","author":"Heidari","year":"2012","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.canlet.2015.02.042_bib0200","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1158\/0008-5472.CAN-13-2003","article-title":"Differential effects of RUNX2 on the androgen receptor in prostate cancer: synergistic stimulation of a gene set exemplified by SNAI2 and subsequent invasiveness","volume":"74","author":"Little","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.canlet.2015.02.042_bib0205","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1476-4598-11-66","article-title":"Integrin \u03b1v\u03b23 and CD44 pathways in metastatic prostate cancer cells support osteoclastogenesis via a Runx2\/Smad5\/receptor activator of NF-\u03baB ligand signaling axis","volume":"11","author":"Gupta","year":"2012","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2015.02.042_bib0210","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1476-4598-11-27","article-title":"Runx2 mediates epigenetic silencing of the bone morphogenetic protein-3B (BMP-3B\/GDF10) in lung cancer cells","volume":"11","author":"Tandon","year":"2012","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2015.02.042_bib0215","doi-asserted-by":"crossref","first-page":"37335","DOI":"10.1074\/jbc.M111.256156","article-title":"Lung tumor-associated osteoblast-derived bone morphogenetic protein-2 increased epithelial-to-mesenchymal transition of cancer by Runx2\/Snail signaling pathway","volume":"286","author":"Hsu","year":"2011","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.canlet.2015.02.042_bib0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2014.09.011","article-title":"Tumor suppressor long non-coding RNA, MT1DP is negatively regulated by YAP and Runx2 to inhibit FoxA1 in liver cancer cells","author":"Yu","year":"2014","journal-title":"Cell. Signal"},{"key":"10.1016\/j.canlet.2015.02.042_bib0225","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/labinvest.2012.84","article-title":"Transcription factor Runx2 is a regulator of epithelial\u2013mesenchymal transition and invasion in thyroid carcinomas","volume":"92","author":"Niu","year":"2012","journal-title":"Lab. Invest"},{"key":"10.1016\/j.canlet.2015.02.042_bib0230","doi-asserted-by":"crossref","first-page":"e75489","DOI":"10.1371\/journal.pone.0075489","article-title":"Cadherin 6 is a new RUNX2 target in TGF-\u03b2 signaling pathway","volume":"8","author":"Sancisi","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.canlet.2015.02.042_bib0235","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s12020-008-9129-z","article-title":"RUNX1 and RUNX2 upregulate Galectin-3 expression in human pituitary tumors","volume":"35","author":"Zhang","year":"2009","journal-title":"Endocrine"},{"key":"10.1016\/j.canlet.2015.02.042_bib0240","doi-asserted-by":"crossref","first-page":"R106","DOI":"10.1186\/bcr3048","article-title":"Metastatic breast cancer cells inhibit osteoblast differentiation through the Runx2\/CBF\u03b2 dependent expression of the Wnt antagonist, sclerostin","volume":"13","author":"Mendoza-Villanueva","year":"2011","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.canlet.2015.02.042_bib0245","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.bbrc.2013.07.131","article-title":"Runx2 induces bone osteolysis by transcriptional suppression of TSSC1","volume":"438","author":"Wang","year":"2013","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"10.1016\/j.canlet.2015.02.042_bib0250","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.oraloncology.2014.06.007","article-title":"Loss of VHL expression contributes to epithelial\u2013mesenchymal transition in oral squamous cell carcinoma","volume":"50","author":"Zhang","year":"2014","journal-title":"Oral Oncol"},{"key":"10.1016\/j.canlet.2015.02.042_bib0255","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1476-4598-13-63","article-title":"MicroRNA-566 activates EGFR signaling and its inhibition sensitizes glioblastoma cells to nimotuzumab","volume":"13","author":"Zhang","year":"2014","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2015.02.042_bib0260","doi-asserted-by":"crossref","first-page":"R89","DOI":"10.1186\/bcr2762","article-title":"Cancer-related ectopic expression of the bone-related transcription factor RUNX2 in non-osseous metastatic tumor cells is linked to cell proliferation and motility","volume":"12","author":"Leong","year":"2010","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.canlet.2015.02.042_bib0265","article-title":"Runx2\u2013smad signaling impacts the progression of tumor-induced bone disease","author":"Zhang","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2015.02.042_bib0270","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.bone.2009.12.027","article-title":"RUNX2 regulates the effects of TNF\u03b1 on proliferation and apoptosis in SaOs-2 cells","volume":"46","author":"Olfa","year":"2010","journal-title":"Bone"},{"key":"10.1016\/j.canlet.2015.02.042_bib0275","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00432-011-1105-y","article-title":"Oral tongue cancer patients show a better overall survival than base of tongue cancer patients","volume":"138","author":"Zhang","year":"2012","journal-title":"J. Cancer Res. Clin. Oncol"},{"key":"10.1016\/j.canlet.2015.02.042_bib0280","doi-asserted-by":"crossref","DOI":"10.2147\/CMAR.S56802","article-title":"Clinical implications of recent studies using mTOR inhibitors to treat advanced hormone receptor-positive breast cancer","author":"Arena","year":"2014","journal-title":"Cancer Manag. Res"},{"key":"10.1016\/j.canlet.2015.02.042_bib0285","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.bbrc.2013.09.130","article-title":"The dual mTORC1 and mTORC2 inhibitor AZD8055 inhibits head and neck squamous cell carcinoma cell growth in vivo and in vitro","volume":"440","author":"Li","year":"2013","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"10.1016\/j.canlet.2015.02.042_bib0290","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1186\/s13058-014-0430-x","article-title":"Overcoming endocrine resistance due to reduced PTEN levels in estrogen receptor-positive breast cancer by co-targeting mammalian target of rapamycin, protein kinase B, or mitogen-activated protein kinase kinase","volume":"16","author":"Fu","year":"2014","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.canlet.2015.02.042_bib0295","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ygyno.2013.11.013","article-title":"YM155 sensitizes ovarian cancer cells to cisplatin inducing apoptosis and tumor regression","volume":"132","author":"Mir","year":"2014","journal-title":"Gynecol. Oncol"},{"key":"10.1016\/j.canlet.2015.02.042_bib0300","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1007\/s00432-014-1734-z","article-title":"YM155 reverses rapamycin resistance in renal cancer by decreasing surviving","volume":"140","author":"Koike","year":"2014","journal-title":"J. Cancer Res. Clin. Oncol"},{"key":"10.1016\/j.canlet.2015.02.042_bib0305","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/cas.12139","article-title":"Novel MEK inhibitor trametinib and other retinoblastoma gene (RB)-reactivating agents enhance efficacy of 5-fluorouracil on human colon cancer cells","volume":"104","author":"Watanabe","year":"2013","journal-title":"Cancer Sci"},{"key":"10.1016\/j.canlet.2015.02.042_bib0310","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.juro.2013.07.019","article-title":"Intravesical instillation of c-MYC inhibitor KSI-3716 suppresses orthotopic bladder tumor growth","volume":"191","author":"Jeong","year":"2014","journal-title":"J. Urol"},{"key":"10.1016\/j.canlet.2015.02.042_bib0315","doi-asserted-by":"crossref","first-page":"943","DOI":"10.3892\/or.2012.1856","article-title":"PTEN activation sensitizes breast cancer to PI3-kinase inhibitor through the \u03b2-catenin signaling pathway","volume":"28","author":"Ren","year":"2012","journal-title":"Oncol. Rep"},{"key":"10.1016\/j.canlet.2015.02.042_bib0320","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1359\/JBMR.040701","article-title":"Growth hormone attenuates the transcriptional activity of Runx2 by facilitating its physical association with Stat3\u03b2","volume":"19","author":"Ziros","year":"2004","journal-title":"J. Bone Miner. Res"},{"key":"10.1016\/j.canlet.2015.02.042_bib0325","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.3892\/or.2014.3114","article-title":"STAT3 inhibitor WP1066 attenuates miRNA-21 to suppress human oral squamous cell carcinoma growth in vitro and in vivo","volume":"31","author":"Zhou","year":"2014","journal-title":"Oncol. Rep"},{"key":"10.1016\/j.canlet.2015.02.042_bib0330","first-page":"195","article-title":"Reduction of miR-21 induces glioma cell apoptosis via activating caspase 9 and 3","volume":"24","author":"Zhou","year":"2010","journal-title":"Oncol. Rep"},{"key":"10.1016\/j.canlet.2015.02.042_bib0335","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/labinvest.2009.126","article-title":"Downregulation of miR-21 inhibits EGFR pathway and suppresses the growth of human glioblastoma cells independent of PTEN status","volume":"90","author":"Zhou","year":"2010","journal-title":"Lab. Invest"},{"key":"10.1016\/j.canlet.2015.02.042_bib0340","first-page":"78","article-title":"Inhibition of human esophageal squamous cell carcinomas bytargeted silencing of tumor enhancer genes: an overview","volume":"11","author":"Islamian","year":"2014","journal-title":"Cancer Biol. Med"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383515001573?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383515001573?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T20:15:27Z","timestamp":1589487327000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383515001573"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":67,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S0304383515001573"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2015.02.042","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of runt-related transcription factor 2 in signal network of tumors as an inter-mediator","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2015.02.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}